Home › Multiple Myeloma › Nevada
Multiple Myeloma clinical trials in Nevada
3 studies for Multiple Myeloma are looking for participants at sites in Nevada.
Cities in Nevada
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
- Renown Health Medical Oncology, Reno
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07609940A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT05623020A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
- Comprehensive Cancer Centers of Nevada, Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07637578From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.